Galderma announced that the U.S. Food and Drug Administration (FDA) has approved Restylane Contour for the correction of temple hollowing in patients over the age of 21. This expands its use beyond cheek augmentation and midface contour deficiencies, helping injectors address volume loss for overall facial balance.

This follows the recent U.S. approval of Restylane Lyft for augmentation of the chin region, adding to its indications to treat the midface, facial folds and wrinkles, back of hands, and the chin. Together, these approvals demonstrate Galderma’s ongoing commitment to evolving the versatile Restylane portfolio to deliver personalized, natural-looking outcomes that meet diverse patient needs.

Temple volume can diminish with age and can be accelerated in people undergoing medication-driven weight loss, a phenomenon which has increased rapidly in recent years resulting in a growing area of aesthetic need. Galderma is spearheading efforts to address these concerns, including with this latest approval for Restylane Contour, which provides a new option for increasing volume in the temples to help restore balance for a more refreshed, youthful look. 

With a dual-layer patent-pending technique leveraging both needle and cannula, Restylane Contour enables healthcare professionals to provide precise, customized, and safe product placement in line with each patient’s aesthetic goals. Restylane Contour is powered by OBT/XpresHAn technology, which integrates into the skin and balances support and flexibility, to provide long-lasting, natural-looking results that move with facial expressions.

The approval is based on clinical results showing that Restylane Contour improved temple hollowing compared with no treatment at three months, with results lasting for up to 18 months. 91% of patients were considered treatment responders at three months, with more than 85% maintaining response through 18 months. High patient and investigator satisfaction was also reported, and all treatment-related adverse events were mild to moderate, with no serious events observed.

Galderma’s new ‘Wake Up To Restylane’ campaign positions Restylane as an everyday natural beauty ally for the face and body, highlighting Galderma’s commitment to meeting emerging needs. Focused on the growing desire for natural, authentic results, the campaign underscores Restylane’s ability to deliver personalized outcomes that move naturally with expression, helping people look refreshed and feel confident in their skin.

Read more about Restylane Contour for Temples >>